Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Alliance Bioenergy Plus Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. The portfolio is managed by 2 distinct examiners across 2 distinct art units. The 2 distinct art units indicate that the company's biotechnology research is categorized into multiple technical areas, suggesting a diverse range of filings. The assigned art units represent the total count of such divisions involved in the company's current prosecution.
OLSON, ANDREA STEFFEL is the busiest examiner, with 1 busiest examiner pending office action. Because there are 2 pending office actions and 2 distinct examiners, the workload is divided between the assigned officials. The 1 busiest examiner pending office action represents the current workload for the busiest examiner in the portfolio. The distinct examiners confirm that the prosecution is shared across different individuals at the office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ANDREA STEFFEL | 1 | 62.4% | -11.9% |
| SEIFU, LESSANEWORK T | 1 | 79.2% | +1.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290711 | SYSTEM AND METHOD TO CONVERT CELLULOSIC MATERIALS INTO SUGAR | OLSON, ANDREA STEFFEL | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18290711 | SYSTEM AND METHOD TO CONVERT CELLULOSIC MATERIALS INTO SUGAR | OLSON, ANDREA STEFFEL | 1693 | §101§103§112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18226224 | SYSTEM TO CONVERT CELLULOSIC MATERIALS INTO SUGAR AND METHOD OF USING THE SAME | SEIFU, LESSANEWORK T | 1774 | §103§112DP | Non-Final OA | — | Pending | Jul 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlliance Bioenergy Plus Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Andrea Steffel Olson has the most, with 1 of Alliance Bioenergy Plus Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
